Genetic Panel for Neuroendocrine Tumors Detection

The lab analyst performs a panel to evaluate the patient specimen for genetic duplications and deletions in at least four genes that the code descriptor lists that may involve mutations (an alteration in DNA that may lead to pathologic changes) associated with hereditary neuroendocrine tumor disorders, abnormal masses that originate from cells of the endocrine or nervous system. Choose a location to see hospital-reported price summaries. This page does not show national, sample, or aggregate pricing.